how to calculate stock price in globus simulation

Registration statement on such date or dates as may be necessary to delay its effective date until the registrant files a further amendment which specifically states that this registration statement shall thereafter become effective in accordance Includes the offering price of shares that the underwriters may purchase pursuant to an option to purchase additional shares. ☐Įstimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forĬomplying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. See the definitions of large accelerated filer, accelerated filer, smaller reportingĬompany and emerging growth company in Rule 12b-2 of the Exchange Act. Indicate by check mark whether the registrant is a largeĪccelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.

If this Form is a post-effective amendment filed pursuant to RuleĤ62(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the sameĤ62(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, asĪdditional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same 139 Main StreetĬambridge, MA 02142 (339) 271 0161 (Name, address, including zip code, and telephone number, including area code, of agent for service)Īpproximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. Chief Executive Officer iTeos Therapeutics, Inc. (Exact name of registrant as specified in its charter)Ĭambridge, MA 02142 (339) 217 0162 (Address, including zip code, and telephone number, including area code, of registrants principal As filed with Securities and Exchange Commission on June 24, 2020

How to calculate stock price in globus simulation